Chemical Engineering in Massachusetts

📊 Employment Overview

Massachusetts employs 651 chemical engineering professionals, representing approximately 2.1% of the national workforce in this field. Massachusetts ranks #15 nationally for chemical engineering employment.

💰 Salary Information

Chemical Engineering professionals in Massachusetts earn competitive salaries across all experience levels, with an average annual salary of $132,000.

Note: Salaries are adjusted for cost of living and local market conditions. Data based on BLS statistics and industry surveys (2024-2025).

🎓 Schools Offering Chemical Engineering

Loading school data...

🚀 Career Insights

Key information for chemical engineering professionals in Massachusetts.

🏢 Industry Landscape & Top Employers

Massachusetts is the nation's fifteenth-largest chemical engineering market by employment — 651 professionals ranking #15 — but arguably the world's most important state for pharmaceutical and biotechnology process chemistry, with a $132,000 average salary reflecting the extraordinary technical premium that the Cambridge-Boston biotech corridor commands globally. Massachusetts is where the most consequential chemical engineering of the 21st century is being done: mRNA vaccine manufacturing scale-up, CAR-T cell therapy process development, gene editing therapeutic manufacturing, and the continuous bioprocessing revolution that is transforming how biologic drugs are made. For ChEs, Massachusetts offers simultaneous access to the most innovative biotech employers, the world's top research universities, and career formation experiences of genuinely global consequence.

Major Employers — Biotechnology and mRNA: Moderna (Cambridge) — whose mRNA COVID-19 vaccine manufacturing scale-up was one of the most consequential pharmaceutical chemical engineering achievements in history — employs chemical engineers in lipid nanoparticle (LNP) formulation process engineering, mRNA synthesis and purification, aseptic fill-finish operations, and manufacturing process development for its growing pipeline of mRNA vaccines and therapeutics. Biogen (Cambridge/Research Triangle) — a pioneer in multiple sclerosis biologics — employs chemical engineers in large-scale mammalian cell culture manufacturing and downstream purification. Sarepta Therapeutics (Cambridge) is developing the manufacturing processes for next-generation gene therapy and mRNA-based Duchenne muscular dystrophy treatments that represent some of the most technically demanding biologic manufacturing challenges in the field.

Major Employers — Specialty and Process Chemicals: Cabot Corporation (Boston) — a global leader in specialty carbons (carbon black), metallic specialty fluids, and activated carbon — employs chemical engineers in process chemistry, materials characterization, and product development. Evonik's Burlington specialty chemicals, W.R. Grace's Cambridge catalyst research center, and the specialty polymers cluster in the Route 128 belt employ chemical engineers in materials process development and customer application engineering. EMD Millipore (Billerica) — MilliporeSigma, a Merck KGaA subsidiary — manufactures filtration membranes, chromatography resins, and analytical standards essential for pharmaceutical manufacturing quality control, employing chemical engineers in membrane process engineering and specialty materials manufacturing.

Key Industry Clusters: Cambridge's Kendall Square / MIT corridor is the world's most valuable square mile of biological process chemistry innovation — Novartis, Pfizer, Sanofi, AstraZeneca, and dozens of well-funded startups cluster around MIT and Harvard's research ecosystems. The Route 128 technology belt (Waltham, Burlington, Woburn, Billerica, Lexington) hosts the established pharmaceutical and specialty chemicals manufacturers. Worcester's UMass Medical School and Astellas Pharma's Northbrook operations create a secondary Central Massachusetts pharmaceutical ChE cluster.

📈 Career Growth & Pathways

Massachusetts chemical engineering careers offer the world's most intellectually demanding and best-compensated pharmaceutical and biotech process engineering environment — the state's career formation value is extraordinary, and engineers who spend 5–10 years mastering mRNA, gene therapy, or continuous bioprocessing in Massachusetts carry credentials sought globally.

• Entry-Level Engineer (0–2 years): $84,000–$105,000 — Moderna's manufacturing sciences entry programs, Biogen's cell culture process engineering associates, and Cambridge biotech startup founding engineer roles are among the world's most competitive pharmaceutical ChE entry positions. MIT, Northeastern (co-op model provides exceptional employer connections), Tufts, and Boston University ChE programs produce the primary talent pipeline. Massachusetts entry-level pharmaceutical ChE salaries are among the nation's highest.
• Mid-Level Engineer (3–7 years): $115,000–$155,000 — Moderna process development engineer owning LNP formulation scale-up for a new mRNA therapeutic program; Biogen downstream purification process engineer optimizing the protein A capture and polishing steps for a new monoclonal antibody; Cambridge biotech process development director at a Series B company translating academic research into GMP-ready manufacturing processes. Total compensation at mid-career in Massachusetts pharmaceutical companies — including equity — routinely exceeds $170,000–$200,000.
• Senior / Staff Engineer (8–14 years): $155,000–$200,000+ — Moderna principal scientist with global mRNA manufacturing standardization responsibility; Biogen's Associate Director of Cell Culture Process Development; Sarepta's gene therapy manufacturing Director. Massachusetts's senior pharmaceutical ChE compensation with equity included can exceed $300,000 at major companies.
• Director / Executive (15+ years): $200,000–$500,000+ — Moderna VP of Manufacturing Sciences with global mRNA production technology responsibility; Biogen Executive Director of Biologics Process Development; Cambridge biotech C-suite technical leadership with IPO or acquisition equity upside that can generate seven-figure wealth events for engineers at companies achieving commercial success.

mRNA Manufacturing as Massachusetts's Defining ChE Achievement: The development and scale-up of mRNA lipid nanoparticle manufacturing for COVID-19 vaccines — accomplished primarily by Moderna in Cambridge and its manufacturing partners — represents arguably the most consequential pharmaceutical process engineering achievement since penicillin production was first scaled at Merck's Rahway facility in the 1940s. The LNP formulation process — precisely controlled microfluidic mixing of ionizable lipids, helper lipids, PEG-lipid, and mRNA to form nanoparticles of uniform size — required chemical engineering solutions that didn't exist at commercial scale in 2020 and were created in months under extraordinary time pressure. Massachusetts's chemical engineers led this work, and the expertise they developed is now the foundation of an entirely new pharmaceutical manufacturing paradigm.

💰 Salary vs. Cost of Living

Massachusetts's $132,000 average chemical engineering salary is second only to California nationally — and for pharmaceutical process engineers in Cambridge or the Route 128 belt, the numbers are substantially higher. The state's cost of living is the most challenging in New England but remains somewhat below California's extreme Bay Area and San Diego costs.

Cambridge / Somerville / Boston: The world's pharmaceutical ChE epicenter. Senior Cambridge biotech ChEs earning $175,000–$250,000+ face housing costs that strain even high salaries — median home prices of $750,000–$1.1M+ in Cambridge and desirable Boston neighborhoods. Most Cambridge pharmaceutical engineers rent ($3,200–$4,500/month for 1-2 bedroom apartments in Somerville, Cambridge, or nearby neighborhoods) or commute from more affordable communities. A $175,000 salary in Cambridge has purchasing power roughly equivalent to $110,000–$120,000 in a median-cost city after housing and Massachusetts income tax.

Route 128 Belt (Waltham / Burlington / Woburn / Billerica): More financially manageable than Cambridge — median home prices of $580,000–$780,000 in quality western Route 128 communities, with pharmaceutical and biotech employers paying $120,000–$185,000 for experienced engineers. Commuting from MetroWest communities (Framingham, Natick, Westborough) provides median home prices of $500,000–$680,000 with reasonable highway access to the pharmaceutical belt.

Worcester Area: The most financially accessible Massachusetts ChE market — median home prices of $380,000–$500,000 and biotech/pharmaceutical employer salaries of $100,000–$150,000 create meaningful purchasing power in a university city with genuine cultural infrastructure.

State Income Tax: Massachusetts's 5% flat income tax (plus a 4% surtax on income above $1 million) is moderate by New England standards but should be factored into comparisons with New Hampshire (no income tax, accessible by commute from the Nashua-Lowell corridor) or Connecticut (graduated rates up to 6.99%).

📜 Licensing & Professional Development

Engineering licensure in Massachusetts is administered by the Board of Registration of Professional Engineers and Professional Land Surveyors. Massachusetts requires 4 years of qualifying experience (standard) and has full NCEES reciprocity. Massachusetts-New Hampshire dual licensure is common for engineers in the Boston-Lowell-Nashua corridor.

Massachusetts PE Licensure Path: Standard NCEES FE → 4 years experience → PE exam. MIT, Northeastern, Tufts, UMass Amherst, and Boston University produce exceptionally well-prepared ChE graduates. Massachusetts's PE exam pass rates among major university graduates are among the highest nationally.

Pharmaceutical Biologics Manufacturing — The Essential Credential Framework: For Massachusetts's world-leading biologics manufacturing community, mastery of FDA's biologics regulatory framework — 21 CFR Part 601 (biologics license applications), ICH Q5A-Q5E (viral safety), Q6B (specifications for biotechnological products), and the specific guidance for cell and gene therapy manufacturing — constitutes the professional competency framework that distinguishes Massachusetts's most capable pharmaceutical ChEs. The convergence of mRNA, gene therapy, and cell therapy manufacturing at Cambridge-area companies is creating demand for chemical engineers who understand aseptic processing, viral vector production, and LNP formulation manufacturing at the frontier of established regulatory science — a genuinely new credential area that Massachusetts engineers are helping define.

Green Chemistry and Process Chemistry: The American Chemical Society's Green Chemistry Institute at MIT and the pharmaceutical industry's adoption of the twelve principles of green chemistry are creating professional development demand for Massachusetts pharmaceutical ChEs who can design inherently safer, more sustainable synthesis routes and manufacturing processes. ACS's CGCN (Green Chemistry and Engineering Network) certification programs are growing in recognition within Massachusetts's pharmaceutical chemistry community.

📊 Job Market Outlook

Massachusetts's chemical engineering market is positioned for continued leadership in the world's most consequential pharmaceutical manufacturing technology — mRNA, gene editing therapeutics, and continuous bioprocessing — creating sustained demand for the world's most technically sophisticated pharmaceutical process engineers in the state that trained most of them.

Gene Therapy Manufacturing Scale-Up: Massachusetts biotechs are leading the development of manufacturing processes for gene therapies — viral vector (AAV, lentiviral) production at commercial scale remains one of the most challenging manufacturing problems in pharmaceutical chemistry, with yields and quality consistency still far from what established biologics manufacturing achieves. The companies that solve this manufacturing challenge at Cambridge will define gene therapy's commercial viability, creating chemical engineering positions of extraordinary professional significance and career impact.

Continuous Bioprocessing Leadership: MIT's Novartis-MIT Center for Continuous Manufacturing and Cambridge-area pharmaceutical companies are pioneering the transition from batch to continuous biopharmaceutical manufacturing — a transformation that promises to reduce drug manufacturing costs by 30–50% while improving quality consistency. Chemical engineers who master the integrated continuous bioprocessing platforms being developed in Massachusetts are building expertise that the global pharmaceutical industry will need to implement over the next 20 years.

5-Year Projection: Massachusetts chemical engineering employment is projected to grow 12–16% over five years. mRNA platform expansion, gene therapy manufacturing, and continuous bioprocessing technology development will drive most growth. Total employment could approach 737–755 by 2029.

🕐 Day in the Life

Chemical engineering in Massachusetts at its best is among the most intellectually stimulating, professionally consequential, and personally fulfilling career experiences available anywhere in the world — the combination of Cambridge's biotech innovation density, MIT and Harvard's adjacent research excellence, and the daily awareness that the manufacturing processes being developed will eventually be used to treat hundreds of thousands of patients creates a professional environment of unique intensity and purpose.

At Moderna (Cambridge): A process development engineer working on Moderna's next-generation respiratory virus mRNA vaccine program navigates one of pharmaceutical manufacturing's most genuinely frontier engineering environments. A morning begins with reviewing the results of a lipid nanoparticle formulation optimization experiment — evaluating how varying the ionizable lipid's molar ratio affects the LNP's encapsulation efficiency, particle size distribution, and polydispersity index. The optimization is guided by a design of experiments methodology using Moderna's automated microfluidic formulation platform, which generates 96-condition experiments overnight that previously would have required weeks of manual labor. The data is analyzed using Moderna's statistical software to build a response surface model that identifies the formulation design space for the new RNA-based influenza vaccine candidate. Mid-morning involves a manufacturing process characterization meeting — Moderna is preparing to manufacture its first clinical batches of the new vaccine candidate, and the process development team is presenting the process development history and scale-up rationale to the manufacturing sciences team that will execute the GMP production runs. The meeting is technically intensive: discussing how the microfluidic mixer's Reynolds number scaling affects LNP formation at manufacturing scale versus development scale, and what additional process parameter characterization experiments are needed before the GMP runs begin. Afternoon involves a literature review and competitor intelligence analysis — examining recent publications on LNP formulation for various mRNA payloads to identify formulation innovations that might improve Moderna's delivery efficiency for the muscle cell targeting required for the influenza vaccine's immunological mechanism.

Lifestyle: Massachusetts offers extraordinary quality of life for engineers who can manage its costs. Cambridge's intellectual energy — the sense of being surrounded by people engaged in genuinely important work, the Nobel laureates giving public lectures, the startups founded in coffee shops that become companies changing medicine — creates a professional and social environment unlike any other. The Red Sox's Fenway Park, the Boston Symphony Orchestra, the Isabella Stewart Gardner Museum, the Charles River Esplanade's running and cycling culture, and the Appalachian Trail's southern terminus in the Berkshires provide cultural and outdoor anchors of real quality. Cape Cod's beaches, Vermont's skiing, and the White Mountains' hiking are weekend accessible. The financial pressure of Massachusetts living is real — but engineers who maximize their time in the Cambridge ecosystem, building credentials and a professional network during their prime earning years, consistently find that the career investment in Massachusetts delivers returns in technical depth, professional reputation, and lifetime earning capacity that no other location can match for pharmaceutical process engineers.

🔄 Compare with Other States

See how Massachusetts compares to other top states for chemical engineering: